Friedman Center for Nutrition
Found 12 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is I  [Clear All Filters]
2023
Topczewska PM, Rompe ZA, Jakob MO, Stamm A, Leclère PS, Preußer A, Duerr CU, Thole LMarie Laur, Kotsch K, Artis D et al..  2023.  ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.. Front Immunol. 14:1130933.
Doron I, Kusakabe T, Iliev ID.  2023.  Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity.. Semin Immunol. 67:101757.
Rajan A, Pan Y, Mahtani P, Niec R, Longman R, Gerber J, Lukin D, Scherl E, Battat R.  2023.  The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease.. Crohns Colitis 360. 5(2):otad017.
Awasthi D, Chopra S, Cho BA, Emmanuelli A, Sandoval TA, Hwang S-M, Chae C-S, Salvagno C, Tan C, Vasquez-Urbina L et al..  2023.  Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis.. J Clin Invest. 133(17)
2021
Teng F, Tachó-Piñot R, Sung B, Farber DL, Worgall S, Hammad H, Lambrecht BN, Hepworth MR, Sonnenberg GF.  2021.  ILC3s control airway inflammation by limiting T cell responses to allergens and microbes.. Cell Rep. 37(8):110051.
Guo C-J.  2021.  Immune activation kickstarts the gut microbiota.. Cell Host Microbe. 29(3):318-320.
Amir M, Zeng MY.  2021.  Immune imprinting in utero.. Science. 373(6558):967-968.
Charilaou P, Tricarico C, Battat R, Scherl EJ, Longman RS, Lukin DJ.  2021.  Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination.. Clin Gastroenterol Hepatol.
Charbord J, Ren L, Sharma RB, Johansson A, Ågren R, Chu L, Tworus D, Schulz N, Charbord P, Stewart AF et al..  2021.  In vivo screen identifies a SIK inhibitor that induces β cell proliferation through a transient UPR.. Nat Metab. 3(5):682-700.
Tchang BG, Askin G, Sahagun A, Hwang J, Huang H, Curanaj FAMendelso, Seley JJ, Safford MM, Alonso LC, Aronne LJ et al..  2021.  The Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study.. Obesity (Silver Spring). 29(6):971-975.
Winkler A, Sun W, De S, Jiao A, M Sharif N, Symanowicz PT, Athale S, Shin JH, Wang J, Jacobson BA et al..  2021.  The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial.. Arthritis Rheumatol. 73(12):2206-2218.
Ma C, Sedano R, Almradi A, Casteele NVande, Parker CE, Guizzetti L, Schaeffer DF, Riddell RH, Pai RK, Battat R et al..  2021.  An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.. Gastroenterology. 160(7):2291-2302.